Skip to main content

Advertisement

SpringerLink
Log in

Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term follow-up in two patients

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

TNF blockers are approved for intravenous or subcutaneous systemic therapy of many chronic inflammatory diseases. As it is not possible to achieve a sufficient local clinical improvement through systemic therapy in every patient, diverse approaches of topical therapy using TNF blockers have been investigated in recent years.

Methods

In this paper, we report on long-term clinical results of originator infliximab (IFX) injections into symptomatic combined scarring and inflammatory stenoses of the rectum in two patients with Crohn’s disease. Aiming at high tissue IFX levels, 25 mg of IFX was injected into each quadrant of the stenosis after endoscopic balloon dilatation. This off-label treatment was repeated as necessary, depending on the clinical success.

Results

Topic IFX injection after balloon dilation reduced imperative stool pressure, isolated episodes of incontinence and incomplete emptying. Improvement lasted between 4 and 14 weeks in one patient and the treatment was repeated 13 times in the following 6.6 years. In the other patient, the technique was necessary only twice with no symptom recurrence in the subsequent 5.3 years.

Conclusion

Our experience suggests that topic application of a systemically approved anti-TNF substance may be a successful individualized therapy for refractory stenosis of the rectum in patients with Crohn’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Solberg IC, Vatn MH, Hoie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I, IBSEN Study Group (2007) Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 5:1430–1438. doi:10.1016/j.cgh.2007.09.002

    Article  PubMed  Google Scholar 

  2. Bettenworth D, Gustavsson A, Atreja A, Lopez R, Tysk C, van Assche G, Rieder F (2017) A pooled analysis of efficacy, safety, and long-term outcome of endoscopic balloon dilation therapy for patients with stricturing Crohn’s disease. Inflamm Bowel Dis 23:133–142. doi:10.1097/MIB.0000000000000988

    Article  PubMed  Google Scholar 

  3. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV Jr (2012) Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970–2004). Am J Gastroenterol 107:1693–1701. doi:10.1038/ajg.2012.298

    Article  PubMed  PubMed Central  Google Scholar 

  4. Navaneethan U, Lourdusamy V, Njei B, Shen B (2016) Endoscopic balloon dilation in the management of strictures in Crohn’s disease: a systematic review and meta-analysis of non-randomized trials. Surg Endosc 30:5434–5443. doi:10.1007/s00464-016-4902-1

    Article  PubMed  Google Scholar 

  5. Chen M, Shen B (2014) Comparable short- and long-term outcomes of colonoscopic balloon dilation of Crohn’s disease and benign non-Crohn’s disease strictures. Inflamm Bowel Dis 20:1739–1746. doi:10.1097/MIB.0000000000000145

    Article  PubMed  Google Scholar 

  6. Ding NS, Yip WM, Choi CH, Saunders B, Thomas-Gibson S, Arebi N, Humphries A, Hart A (2016) Endoscopic dilatation of Crohn’s anastomotic strictures is effective in the long term, and escalation of medical therapy improves outcomes in the biologic era. J Crohns Colitis 10:1172–1178. doi:10.1093/ecco-jcc/jjw072

    Article  PubMed  Google Scholar 

  7. Brooker JC, Beckett CG, Saunders BP, Benson MJ (2003) Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome: a retrospective case series. Endoscopy 35:333–337. doi:10.1055/s-2003-38145

    Article  CAS  PubMed  Google Scholar 

  8. van der Have M, Noomen C, Oldenburg B, Walter D, Houben MH, Wasser MN, Siersema PD, Hommes D, Fidder HH (2015) Balloon dilatation with or without intralesional and oral corticosteroids for anastomotic Crohn’s disease strictures. J Gastrointestin Liver Dis 24:537–539. doi:10.15403/jgld.2014.1121.244.hav

    PubMed  Google Scholar 

  9. Biancone L, Cretella M, Tosti C, Palmieri G, Petruzziello C, Geremia A, Calabrese E, Pallone F (2006) Local injection of infliximab in the postoperative recurrence of Crohn’s disease. Gastrointest Endosc 63:486–492. doi:10.1016/j.gie.2005.08.047

    Article  PubMed  Google Scholar 

  10. Swaminath A, Lichtiger S (2008) Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn’s colitis. Inflamm Bowel Dis 14:213–216. doi:10.1002/ibd.20318

    Article  PubMed  Google Scholar 

  11. Bettenworth D, Rieder F (2014) Medical therapy of stricturing Crohn’s disease: what the gut can learn from other organs—a systematic review. Fibrogenesis Tissue Repair 7:5. doi:10.1186/1755-1536-7-5

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rieder F, Kessler S, Sans M, Fiocchi C (2012) Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol 303:G786–G801. doi:10.1152/ajpgi.00059.2012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Schatteman L, Gyselbrecht L, De Clercq L, Mielants H (2006) Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. J Rheumatol 33:82–85

    CAS  PubMed  Google Scholar 

  14. Conti F, Ceccarelli F, Priori R, Iagnocco A, Signore A, Valesini G (2008) Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha. Ann Rheum Dis 67:1787–1790. doi:10.1136/ard.2008.091900

    Article  CAS  PubMed  Google Scholar 

  15. Poggioli G, Laureti S, Pierangeli F, Rizzello F, Ugolini F, Gionchetti P, Campieri M (2005) Local injection of infliximab for the treatment of perianal Crohn’s disease. Dis Colon rectum 48:768–774. doi:10.1007/s10350-004-0832-4

  16. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F (2006) Treatment of perianal fistulas in Crohn’s disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand J Gastroenterol 41:1064–1072. doi:10.1080/00365520600609941

    Article  CAS  PubMed  Google Scholar 

  17. Alessandroni L, Kohn A, Cosintino R, Marrollo M, Papi C, Monterubbianesi R, Tersigni R (2011) Local injection of infliximab in severe fistulating perianal Crohn’s disease: an open uncontrolled study. Tech Coloproctol 15:407–412. doi:10.1007/s10151-011-0759-4

    Article  CAS  PubMed  Google Scholar 

  18. Poggioli G, Laureti S, Pierangeli F, Bazzi P, Coscia M, Gentilini L, Gionchetti P, Rizzello F (2010) Local injection of adalimumab for perianal Crohn’s disease: better than infliximab? Inflamm Bowel Dis 16:1631. doi:10.1002/ibd.21210

    Article  CAS  PubMed  Google Scholar 

  19. Tonelli F, Giudici F, Asteria CR (2012) Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn’s disease: a pilot study. Dis Colon rectum 55:870–875. doi:10.1097/DCR.0b013e31825af532

  20. Lorenzo-Zúñiga V, Boix J, Mañosa M, Lezcano C, Cabré E, de Vega VM, Domènech E (2013) Local injection of infliximab in symptomatic isolated mucosal lesions: a novel scenario for endoscopic therapy? Inflamm Bowel Dis 19:E59–E61. doi:10.1002/ibd.23018

    Article  PubMed  Google Scholar 

  21. D'Alessandria C, Malviya G, Viscido A, Aratari A, Maccioni F, Amato A, Scopinaro F, Caprilli R, Signore A (2007) Use of a 99mTc labeled anti-TNFalpha monoclonal antibody in Crohn’s disease: in vitro and in vivo studies. Q J Nucl Med Mol Imaging 51:334–342

    PubMed  Google Scholar 

  22. Conti F, Malviya G, Ceccarelli F, Priori R, Iagnocco A, Valesini G, Signore A (2012) Role of scintigraphy with (99m)Tc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis. Eur J Nucl Med Mol Imaging 39:1339–1347. doi:10.1007/s00259-012-2133-9

    Article  CAS  PubMed  Google Scholar 

  23. Atreya R, Neumann H, Neufert C, Waldner MJ, Billmeier U, Zopf Y, Willma M, App C, Münster T, Kessler H, Maas S, Gebhardt B, Heimke-Brinck R, Reuter E, Dörje F, Rau TT, Uter W, Wang TD, Kiesslich R, Vieth M, Hannappel E, Neurath MF (2014) In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn’s disease. Nat Med 20:313–318. doi:10.1038/nm.3462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselkrankheiten Leipzig und Schkeuditz, Nordstr. 21, 04105, Leipzig, Germany

    Niels Teich

  2. Klinikum St. Georg gGmbH, Klinik für Gastroenterologie und Hepatologie, Leipzig, Germany

    Niels Teich, Ingo Wallstabe & Ingolf Schiefke

Authors
  1. Niels Teich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ingo Wallstabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ingolf Schiefke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niels Teich.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest. This study had no funding source.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teich, N., Wallstabe, I. & Schiefke, I. Topic infliximab injection for refractory rectal stenosis in Crohn’s disease: long-term follow-up in two patients. Int J Colorectal Dis 32, 1289–1294 (2017). https://doi.org/10.1007/s00384-017-2860-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-017-2860-2

Keywords

Search

Navigation